Get started
Author

Marouan Zarrouk

AMPK α1: A glucose sensor that controls CD 8 T ‐cell memory
2013 · Julia Rolf, Marouan Zarrouk, et al. · European Journal of Immunology · 242
PDF
Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature
2020 · Jannik Stemler, Kamal Hamed, et al. · Mycoses · 50
PDF
In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin
2009 · David J. Killock, Maddy Parsons, et al. · Journal of Biological Chemistry · 47
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
2014 · Marouan Zarrouk, David K. Finlay, et al. · PLoS ONE · 42
PDF
A randomised controlled multicentre investigator-blinded clinical trial comparing efficacy and safety of surgery versus complex physical decongestive therapy for lipedema (LIPLEG)
2021 · Maurizio Podda, Maximilian Kovacs, et al. · Trials · 36
PDF
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature
2019 · Jannik Stemler, Jon Salmanton‐García, et al. · Mycoses · 27
PDF
Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
2018 · Friederike Schaub, Robert Hoerster, et al. · Trials · 22
PDF
LKB1 Mediates the Development of Conventional and Innate T Cells via AMP-Dependent Kinase Autonomous Pathways
2013 · Marouan Zarrouk, Julia Rolf, et al. · PLoS ONE · 17
PDF
Protein kinase D isoforms are dispensable for integrin‐mediated lymphocyte adhesion and homing to lymphoid tissues
2012 · Sharon A. Matthews, Hwee San Lek, et al. · European Journal of Immunology · 11
PDF
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
2022 · Julia M. Neuhann, Jannik Stemler, et al. · Trials · 10
PDF
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
2023 · Julia M. Neuhann, Jannik Stemler, et al. · Vaccine · 8
1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study
2020 · Danila Seidel, Oliver Cornely, et al. · Open Forum Infectious Diseases · 2
PDF
Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)–final report
2026 · Jannik Stemler, Lusine Yeghiazaryan, et al. · International Journal of Infectious Diseases · 1
PDF
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
2024 · Jannik Stemler, Lusine Yeghiazaryan, et al. · International Journal of Infectious Diseases · 1
PDF
2383. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised trial in adults ≥75 years (EU-COVAT-1) from the VACCELERATE consortium
2023 · Jon Salmanton-Garcia, Julia M Neuhann, et al. · Open Forum Infectious Diseases · 1
PDF
Immunogenicity and Reactogenicity of a First Booster with NT162b2or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1)
2023 · Julia Neuhann, Jannik Stemler, et al. · SSRN Electronic Journal · 1
Monitoring RhoGTPase Activity in Lymphocytes
2010 · Marouan Zarrouk, David Killock, et al. · Methods in molecular biology · 1
Immunogenicity, Reactogenicity and Safety to Assess Booster Vaccinations with BNT162b2 or Full-Dose mRNA-1273 in Adults ≥75 Years (EU-COVAT-1-AGED) – Final Report
2025 · Jannik Stemler, Lusine Yeghiazaryan, et al. · SSRN Electronic Journal
Immunogenicity, Reactogenicity and Safety of a Second Booster with BNT162b2 or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1-AGED Part B)
2023 · Jannik Stemler, Lusine Yeghiazaryan, et al. · SSRN Electronic Journal
STUDY PROTOCOL A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE network
2022 · Julia Maria Neuhann, Jannik Stemler, et al. · Research Square
PDF
2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study
2019 · Danila Seidel, Oliver Cornely, et al. · Open Forum Infectious Diseases
Monitoring RhoGTPase Activity in Leukocytes Using Classic “Pull-Down” Assays
2017 · Marouan Zarrouk, David Killock, et al. · Methods in molecular biology
PO032 Epidemiology and classification of MDS: 74 cases
2007 · M. Bedoui, H. Ben Abid, et al. · Leukemia Research
Works count: 40
Citation count: 522
H-index: 10
I10-index: 10
Year
Topic
Type